The results of a micro-cap company specializing in the business of manufacturing bulk chemicals are out for the FY25, followed by robust results, with the net profits up by 1732 percent YoY Check it out.
Price action
With a market capitalization of Rs. 813.22 crores on Monday, the shares of Amal Ltd were trading at a CMP of Rs 644.65, which is 2 percent lower than its previous closing price of Rs 657.80.
What Happened
Amal Ltd, a micro-cap company, which is engaged in manufacturing and marketing bulk chemicals, has announced its results for the Financial year ‘25.
Its Revenue from operations grew by 84 percent YoY from Rs 21.2 Crores in Q4FY24 to Rs 39.0 Crores in Q4FY25, but the same net profits have reduced by 15 percent QoQ from Rs 45.8 Crores in Q3FY25 to Rs 39.0 Crores in Q4FY25.
Its Net Profit grew by a staggering 1732 percent YoY from Rs. 0.37 Crores in Q4FY24 to Rs. 6.78 Crores in Q4FY25, but it has dipped from the previous quarter by 59 percent from Rs. 16.5 Crores in Q3FY25 to Rs. 6.78 Crores in Q4FY25.
The Earnings Before Interest, Depreciation, and Taxes (EBIDT) of the company has grown by 163 percent YOY from Rs.3.99 crores in Q4FY24 to Rs.10.5 crores in Q4FY25.
The company’s EPS has also grown by 1727 percent YOY from Rs.0.30 in Q4FY24 to Rs. 5.48 in Q4FY25, and it has reduced by 59 percent QoQ from Rs. 13.38 in Q3FY25 to Rs. 5.48 in Q4FY25.
About the company:
Amal Ltd is a part of Atul Ltd. It is an Ankleshwar, Gujarat-based chemical company engaged in manufacturing and marketing bulk chemicals such as Sulphuric Acid and Oleum, and their downstream products such as Sulphur Dioxide and Sulphur Trioxide
The company has implemented various projects which includes a multi-purpose modern EOU to manufacture bulk drugs in Pardi, Gujarat. It has also set up an oleum / sulphuric acid and a bulk drug project. The company has implemented projects to manufacture oleum and 1200 tpa pigments in Ankleshwar and expanded the existing capacities of the Ankleshwar and Roha units.
Written by Likesh Babu S
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
